Tag: Bristol-Myers
Dax schließt im Plus und festigt seinen Aufwärtstrend
Düsseldorf Am deutschen Aktienmarkt bleibt die Stimmung am Dienstag weiter freundlich. Der Dax steigt bis zum Handelsschluss um 0,9 Prozent auf 15.930 Punkte. Bereits am Montag legte der Leitindex um…
Finding capital for biotech companies remains difficult
biotech research German biotech companies currently have many drugs in clinical trials. (Photo: IMAGO / Shotshop) Frankfurt Since the boom during the corona pandemic, German biotech companies have been raising…
Billion dollar deal for Munich biotech start-up Tubulis
Tubulis logo The young biotech company could earn over a billion dollars with the partnership. (Photo: tubules) Frankfurt The Munich-based biotech company Tubulis has agreed a potentially multi-billion dollar deal…
Biontech secures new cancer drug with deal worth millions
Biontech founder Ugur Sahin The company is currently also growing through acquisitions. (Photo: imago images/photothek) Frankfurt With one of its largest deals to date, Biontech is expanding its product development…
Pfizer acquires cancer specialist Seagen for $43 billion
Pfizer logo The US pharmaceutical company takes over the cancer specialist Seagen for 43 billion dollars. (Photo: AP) Frankfurt The US group Pfizer is using its billions in revenue from…
Undercover biotech star expands into cell therapy
Frankfurt Novel cell and gene therapies have been causing a sensation in medicine for several years. German pharmaceutical companies do not yet play a major role here. But a biotech…
Undercover biotech star expands into cell therapy
Frankfurt Novel cell and gene therapies have been causing a sensation in medicine for several years. German pharmaceutical companies do not yet play a major role here. But a biotech…
Dax group Bayer is again showing confidence in the growth of its pharmaceutical division
Frankfurt Bayer believes its pharmaceuticals division will grow faster in the long term than previously assumed by many external observers. The Dax group has now almost doubled the sales forecast…
Dax group Bayer is again showing confidence in the growth of its pharmaceutical division
Frankfurt Bayer believes its pharmaceuticals division will grow faster in the long term than previously assumed by many external observers. The Dax group has now almost doubled the sales forecast…
After the Corona boom, the pharmaceutical industry is facing a dip in growth
Frankfurt In the past two years, the corona pandemic has given the pharmaceutical industry the strongest sales boost in decades. But the boom is abating and the industry will have…
Dax closes again in the red – professionals experience friendly “Witches’ Sabbath”
Dusseldorf The five-week sideways phase in the leading German index has ended. Now, investors should pay attention to the downside. On Friday, the leading index lost another 0.7 percent and…
Morphosys: Biotech pioneer in the crisis of confidence
Medical research (icon image) Morphosys share price still fails to recover. (Photo: IMAGO/Westend61) Frankfurt After failures at research partners and disappointing sales figures for its first own drug, the Munich…
Biotech stocks are interesting for investors
Blood cancer cells and immunoglobins The biotech company Amgen develops therapies against cancer. In late August, Amgen’s stock rose 7 percent after it acquired another biotech company. (Photo: obs) Cologne…
US indices close slightly higher – imminent strike weighs on railway stocks
Wall Street in New York The Fed could make another rate hike in September. (Photo: AP) Frankfort, New York Price data welcomed with relief eases selling pressure on Wall Street.…
Investors in the US are keen to buy – tech stocks are picking up
Wall Street in New York The Fed could make another rate hike in September. (Photo: AP) Frankfort, New York The lower price level and the prospect of an easing of…
Bayer dares big bet on anticoagulant drug Asundexian
Frankfurt The Bayer Group announced one of its largest clinical study programs to date over the weekend. The goal: to develop a successor product for the current bestseller Xarelto. The…
Bayer dares big bet on anticoagulant drug Asundexian
Frankfurt The Bayer Group announced one of its largest clinical study programs to date over the weekend. The goal: to develop a successor product for the current bestseller Xarelto. The…
Michael Burry prepares for Crash
Michael Burry The star investor believes the current upside is a bear market rally and has sold all but one stock. (Photo: Getty Images) Dusseldorf While the mood on Wall…
Donald Trump’s grip on the electoral systems – Morning Briefing
it sounds like a passage from a Dan Brown novel, but what about Donald Trump and those around him doesn’t evoke political fiction? According to the Washington Post, after the…
Michael Burry prepares for Crash
Michael Burry The star investor believes the current upside is a bear market rally and has sold all but one stock. (Photo: Getty Images) Dusseldorf While the mood on Wall…